Soleno Therapeutics Inc
F:6XC1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Soleno Therapeutics Inc
F:6XC1
|
US |
|
Immobiliere Dassault SA
PAR:IMDA
|
FR |
|
P
|
Petroleo Brasileiro SA Petrobras
XBER:PJX
|
BR |
|
Alphabet Inc
LSE:0HD6
|
US |
|
Freund Corp
TSE:6312
|
JP |
|
Abb Ltd
F:ABJ
|
CH |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
Silver Mountain Resources Inc
TSX:AGMR
|
CA |
|
Atrium Ljungberg AB
F:A1A0
|
SE |
|
S
|
Sasfin Holdings Ltd
JSE:SFN
|
ZA |
|
K
|
Kikkoman Corp
SWB:KIK
|
JP |
|
Corporacion Inmobiliaria Vesta SAB de CV
OTC:VESTF
|
MX |
|
F
|
freenet AG
SWB:FNTN
|
DE |
|
I
|
Industria de Diseno Textil SA
WSE:ITX
|
ES |
|
R
|
Renalytix PLC
OTC:RTNXF
|
UK |
|
Viscofan SA
BMV:VISCN
|
ES |
|
P
|
Pharol SGPS SA
SWB:PTCA
|
PT |
|
A
|
Applied Blockchain Inc
NASDAQ:APLD
|
US |
|
S
|
Sartorius Stedim Biotech SA
SWB:56S1
|
FR |
Bankruptcy Probability
Soleno Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Soleno Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
2.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Soleno Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Soleno Therapeutics Inc has total debt of 49.9m USD. This includes both short-term (0 USD) and long-term (49.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
